Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD
SALT LAKE CITY, July 13, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biol…
